1. Home
  2. ABEO vs NFGC Comparison

ABEO vs NFGC Comparison

Compare ABEO & NFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • NFGC
  • Stock Information
  • Founded
  • ABEO 1974
  • NFGC 2016
  • Country
  • ABEO United States
  • NFGC Canada
  • Employees
  • ABEO N/A
  • NFGC N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • NFGC Precious Metals
  • Sector
  • ABEO Health Care
  • NFGC Basic Materials
  • Exchange
  • ABEO Nasdaq
  • NFGC Nasdaq
  • Market Cap
  • ABEO 256.9M
  • NFGC 261.0M
  • IPO Year
  • ABEO 1980
  • NFGC N/A
  • Fundamental
  • Price
  • ABEO $5.57
  • NFGC $1.42
  • Analyst Decision
  • ABEO Strong Buy
  • NFGC Strong Buy
  • Analyst Count
  • ABEO 6
  • NFGC 1
  • Target Price
  • ABEO $18.00
  • NFGC $5.00
  • AVG Volume (30 Days)
  • ABEO 1.1M
  • NFGC 905.5K
  • Earning Date
  • ABEO 08-11-2025
  • NFGC 08-08-2025
  • Dividend Yield
  • ABEO N/A
  • NFGC N/A
  • EPS Growth
  • ABEO N/A
  • NFGC N/A
  • EPS
  • ABEO N/A
  • NFGC N/A
  • Revenue
  • ABEO N/A
  • NFGC N/A
  • Revenue This Year
  • ABEO N/A
  • NFGC N/A
  • Revenue Next Year
  • ABEO $323.51
  • NFGC N/A
  • P/E Ratio
  • ABEO N/A
  • NFGC N/A
  • Revenue Growth
  • ABEO N/A
  • NFGC N/A
  • 52 Week Low
  • ABEO $3.93
  • NFGC $0.93
  • 52 Week High
  • ABEO $7.32
  • NFGC $3.65
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 37.51
  • NFGC 48.48
  • Support Level
  • ABEO $5.66
  • NFGC $1.43
  • Resistance Level
  • ABEO $6.24
  • NFGC $1.50
  • Average True Range (ATR)
  • ABEO 0.26
  • NFGC 0.06
  • MACD
  • ABEO -0.08
  • NFGC -0.02
  • Stochastic Oscillator
  • ABEO 8.08
  • NFGC 14.29

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About NFGC New Found Gold Corp

New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).

Share on Social Networks: